Diabetic therapeutic shoes for the department of veterans affairs, veterans health administration

The U.S. Department of Veterans Affairs (VA), through the Office of Procurement, Acquisition and Logistics (OPAL) on behalf of the Veterans Health Administration (VHA) and Strategic Acquisition Center (SAC), is conducting market research to identify vendors capable of producing and supplying PDAC-approved diabetic therapeutic shoes for nationwide usage across the veteran population. This Request for Information (RFI) seeks input from all business categories, including large businesses, small businesses, Service-Disabled Veteran-Owned Small Businesses (SDVOSB), and Veteran-Owned Small Businesses (VOSB). Key requirements include the availability of modern casual and athletic style therapeutic footwear in multiple colors with full-length, heel-to-toe removable fillers providing a minimum of 3/16-inch additional depth for custom-molded inserts; construction from leather or equivalent materials; availability in full and half sizes with a minimum of three width gradations per the American Standard Last Sizing Schedule; compliance with Buy American Act (BAA) or Trade Agreement Act (TAA) requirements; and replacement inserts that meet Centers for Medicare & Medicaid Services (CMS) requirements for HCPCS codes A5510 and A5512. The applicable NAICS codes are 316210 (Footwear Manufacturing) or 339112 (Surgical and Medical Instrument Manufacturing), with a small business size standard of 1,000 employees. Vendors must submit responses by 3:00 PM EST on February 2, 2026, to Contracting Officer Anna Norcross at Anna.Norcross@va.gov, with responses being voluntary, non-binding, and not returned to respondents.

This pre-solicitation notice contains no set-aside designation, meaning all eligible business types may compete. No incumbent contractors or current contract values are identified in the available documentation. The procurement does not specify a particular award value or budget range at this RFI stage, as the primary objective is to conduct market research and assess vendor availability and capability. The requirement encompasses 84 total therapeutic shoe sizes across men's and women's footwear, organized by three width categories (Medium, Wide, and Extra Wide) with men's sizes ranging from 6.0 to 14.0 and women's sizes ranging from 5.0 to 13.0. Vendors responding to the RFI should provide company information, a capability statement, and detailed responses regarding their operational and logistical capabilities, including manufacturing or distribution status, web-based ordering systems, delivery methods to VA facilities, shipping timelines, and return and refund policies. While this is a pre-solicitation notice with a February 9, 2026 posting deadline, the actual RFI response deadline is February 2, 2026, and respondents should not expect notification of review results following submission.